Recent Finacing
Recent Raise
Santero, a Charleroi spin-off of Université libre de Bruxelles, develops first-in-class antibiotic inhibitors targeting multi-drug-resistant, especially Gram-negative, bacterial infections and advances lead programs toward clinical development.
